Literature DB >> 1802583

Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months.

R L Mehta1, B R McDonald, D M Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1802583     DOI： 10.1159/000420221

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  8 in total

Review 1.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

2.  Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia.

Authors:  V Srámek; I Novák; M Matĕjovic; R Rokyta; M Nalos; P Hora; H Pittrová
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

Review 3.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

4.  Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.

Authors:  Josée Bouchard; François Madore
Journal:  NDT Plus       Date:  2008-12-09

5.  Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.

Authors:  Louise Schilder; S Azam Nurmohamed; Frank H Bosch; Ilse M Purmer; Sylvia S den Boer; Cynthia G Kleppe; Marc G Vervloet; Albertus Beishuizen; Armand R J Girbes; Pieter M Ter Wee; A B Johan Groeneveld
Journal:  Crit Care       Date:  2014-08-16       Impact factor: 9.097

6.  Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.

Authors:  Paulien A M A Raymakers-Janssen; Marc Lilien; Ingrid A van Kessel; Esther S Veldhoen; Roelie M Wösten-van Asperen; Josephus P J van Gestel
Journal:  Pediatr Nephrol       Date:  2017-06-04       Impact factor: 3.714

7.  Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.

Authors:  Wei Zhang; Ming Bai; Yan Yu; Lu Li; Lijuan Zhao; Shiren Sun; Xiangmei Chen
Journal:  Crit Care       Date:  2019-01-24       Impact factor: 9.097

8.  Renal replacement therapy for acute renal failure in children: European guidelines.

Authors:  Vladimirs Strazdins; Alan R Watson; Ben Harvey
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.